4.7 Review

Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus

Journal

EMBO REPORTS
Volume 13, Issue 3, Pages 204-215

Publisher

WILEY
DOI: 10.1038/embor.2012.11

Keywords

Merlin; type 2 neurofibromatosis; contact inhibition; tumour suppression; Hippo

Funding

  1. National Institutes of Health [R01 CA152975]
  2. Cancer Center Support Grant [P30 CA08748]
  3. Children's Tumor Foundation

Ask authors/readers for more resources

Inhibition of proliferation by cell-to-cell contact is essential for tissue organization, and its disruption contributes to tumorigenesis. The FERM domain protein Merlin, encoded by the NF2 tumour suppressor gene, is an important mediator of contact inhibition. Merlin was thought to inhibit mitogenic signalling and activate the Hippo pathway by interacting with diverse target-effectors at or near the plasma membrane. However, recent studies highlight that Merlin pleiotropically affects signalling by migrating into the nucleus and inducing a growth-suppressive programme of gene expression through its direct inhibition of the CRL4(DCAF1) E3 ubiquitin ligase. In addition, Merlin promotes the establishment of epithelial adhesion and polarity by recruiting Par3 and aPKC to E-cadherin-dependent junctions, and by ensuring the assembly of tight junctions. These recent advances suggest that Merlin acts at the cell cortex and in the nucleus in a similar, albeit antithetic, manner to the oncogene beta-catenin.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available